What is the address of NGC MED?

The registered office of NGC MED is located at Dwersbos 125, 1650 Beersel.

Is NGC MED still active?

Yes. According to the CBE (18 September 2026) NGC MED is active, legal situation “Normale toestand”, started on 23 July 2019.

Is NGC MED registered on Peppol?

No, NGC MED is currently not registered on the Peppol network.

What is the enterprise number of NGC MED?

The enterprise number of NGC MED is BE0730957554.

When was NGC MED founded?

NGC MED was founded on 23 July 2019.

Who are the directors of NGC MED?

According to the 2025 annual accounts, the directors of NGC MED are: NELIDA CIUPILAN.

Is NGC MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 July 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did NGC MED make in 2025?

NGC MED posted a profit after taxes of € 96,789 in financial year 2025.

What is the revenue of NGC MED?

As a small company, NGC MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 171,013.

NGC MED (Private Limited) - Beersel - BE0730957554

Dossier NGC MED, printed on 18 September 2026 from databakkes.be/en/0730957554/ngc-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

NGC MED from Beersel, company number BE0730957554, closed financial year 2025 with a result of € 96,789 after tax. For that financial year NGC MED recorded a gross margin of € 171,013 and equity of € 254,109. Compared with financial year 2024, the result moved from € 66,058 to € 96,789. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 254,109

▲ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 96,789

▲ 47% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 110,019

▲ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 249,109.

People and assets in 2025

Vehicles and equipment

€ 3,278

▼ 61% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 129,694

▼ 20% vs 2024

€ 29,484 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,463

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 20,476

▲ 201% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 76,575 Gross margin 2022: € 76,575 First fiscal year in the series	€ 80,394 Gross margin 2023: € 80,394 ▲ 5% vs 2022 (€ 76,575) Favourable step	€ 135,144 Gross margin 2024: € 135,144 ▲ 68% vs 2023 (€ 80,394) Favourable step	€ 171,013 Gross margin 2025: € 171,013 ▲ 27% vs 2024 (€ 135,144) Favourable step	▲ 27%
Profit after taxes	€ 31,180 Profit after taxes 2022: € 31,180 First fiscal year in the series	€ 26,875 Profit after taxes 2023: € 26,875 ▼ 14% vs 2022 (€ 31,180) Unfavourable step	€ 66,058 Profit after taxes 2024: € 66,058 ▲ 146% vs 2023 (€ 26,875) Favourable step	€ 96,789 Profit after taxes 2025: € 96,789 ▲ 47% vs 2024 (€ 66,058) Favourable step	▲ 47%
Equity	€ 64,386 Equity 2022: € 64,386 First fiscal year in the series	€ 91,262 Equity 2023: € 91,262 ▲ 42% vs 2022 (€ 64,386) Favourable step	€ 157,320 Equity 2024: € 157,320 ▲ 72% vs 2023 (€ 91,262) Favourable step	€ 254,109 Equity 2025: € 254,109 ▲ 62% vs 2024 (€ 157,320) Favourable step	▲ 62%
Total debts	€ 245,445 Total debts 2022: € 245,445 First fiscal year in the series	€ 209,117 Total debts 2023: € 209,117 ▼ 15% vs 2022 (€ 245,445) Favourable step	€ 168,335 Total debts 2024: € 168,335 ▼ 20% vs 2023 (€ 209,117) Favourable step	€ 151,633 Total debts 2025: € 151,633 ▼ 10% vs 2024 (€ 168,335) Favourable step	▼ 10%
Cash	€ 68,813 Cash 2022: € 68,813 First fiscal year in the series	€ 96,925 Cash 2023: € 96,925 ▲ 41% vs 2022 (€ 68,813) Favourable step	€ 83,919 Cash 2024: € 83,919 ▼ 13% vs 2023 (€ 96,925) Unfavourable step	€ 110,019 Cash 2025: € 110,019 ▲ 31% vs 2024 (€ 83,919) Favourable step	▲ 31%
Retained profit	€ 59,386 Retained profit 2022: € 59,386 First fiscal year in the series	€ 86,262 Retained profit 2023: € 86,262 ▲ 45% vs 2022 (€ 59,386) Favourable step	€ 152,320 Retained profit 2024: € 152,320 ▲ 77% vs 2023 (€ 86,262) Favourable step	€ 249,109 Retained profit 2025: € 249,109 ▲ 64% vs 2024 (€ 152,320) Favourable step	▲ 64%
Bank debt	€ 233,395 Bank debt 2022: € 233,395 First fiscal year in the series	€ 195,620 Bank debt 2023: € 195,620 ▼ 16% vs 2022 (€ 233,395) Favourable step	€ 161,506 Bank debt 2024: € 161,506 ▼ 17% vs 2023 (€ 195,620) Favourable step	€ 129,694 Bank debt 2025: € 129,694 ▼ 20% vs 2024 (€ 161,506) Favourable step	▼ 20%
Balance sheet total	€ 309,831 Balance sheet total 2022: € 309,831 First fiscal year in the series	€ 300,379 Balance sheet total 2023: € 300,379 ▼ 3% vs 2022 (€ 309,831) Unchanged	€ 325,655 Balance sheet total 2024: € 325,655 ▲ 8% vs 2023 (€ 300,379) Unchanged	€ 405,742 Balance sheet total 2025: € 405,742 ▲ 25% vs 2024 (€ 325,655) Unchanged	▲ 25%

Key figures of NGC MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to NGC MED?

What happened at NGC MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 96,789 (▲ 47% vs 2024). filed late Source: NBB ↗
Jul 23, 2019 Start of the company according to the CBE. KBO

In short

From € 31,180 profit in 2022 to € 96,789 profit in 2025.

Paid € 80,767 in corporate taxes since 2022.

Best year ever: 2025, with € 96,789 profit.

Original PDFs at the National Bank ↗

A new publication or filing at NGC MED? We notify you, reason included.

Follow NGC MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

NELIDA CIUPILAN

NGC MED

Behind NGC MED is NELIDA CIUPILAN.

See the full network in the app

Directors

According to the 2025 annual accounts

NELIDA CIUPILAN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dwersbos 125

1650 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0730.957.554
VAT number: BE 0730.957.554
Registered office: Dwersbos 125, 1650 Beersel
Names & denominations: NGC MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 July 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗